AXYS Pharmaceuticals is Biotechnology in United States that focus on system disorders business. Founded in 1989. They cover business area such as Integrator, drug discovery technology, gene distribution, clinical development, small molecule therapeutic, therapeutic area, respiratory, cardiovascular, metabolic and infectious disease, oncology, central nervous system disorder.
1989
( 35 years old in 2024 )
System Disorders
-
180 Kimball Way
South San Francisco
South San Francisco, CA 94080
United States
Private
Integratordrug discovery technologygene distributionclinical developmentsmall molecule therapeutictherapeutic arearespiratory, cardiovascular, metabolic and infectious diseaseoncologycentral nervous system disorder
* We use standard office opening hours in near AXYS Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
AXYS Pharmaceuticals is Biotechnology business from United States that founded in 1989 (35 years old in 2024), AXYS Pharmaceuticals business is focusing on System Disorders.
AXYS Pharmaceuticals headquarter office and corporate office address is located in 180 Kimball Way South San Francisco South San Francisco, CA 94080 United States.
AXYS Pharmaceuticals was founded in United States.
In 2024, AXYS Pharmaceuticals is currently focus on system disorders sector.
Above is snippet of Google Trends for "system disorders" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with AXYS Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
